Control group:Standard medical treatment
Sponsors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Department of Neurology, Maoming people's Hospital, The Second Affiliated Hospital of the Army Medical University, The First Affiliated Hospital of Guangzhou Medical University, Zhejiang Hospital
Conditions
Acute Ischemic StrokeCOVID-19 diseasesChronic obstructive pulmonary diseaseHBV-related liver failureLarge vessel occlusion strokeNovel Coronavirus Pneumonia (COVID-19)Severe pneumoniaischemic stroke
Early Phase 1
To compare the efficacy and safety of stereotactic aspiration plus urokinase versus standard medical treatment for patients with spontaneous supratentorial intracerebral hemorrhage based on the guiding of diffusion tensor imaging-2
RecruitingChiCTR2000040886
Start: 2021-01-01Updated: 2021-04-12
Study on metabonomics and fecal-microbiota transplantation to improve nutrition and prognosis in convalescent stage of severe pneumonia
Active, not recruitingChiCTR2100053312
Start: 2021-12-01Updated: 2022-10-17
A randomized controlled trial and mechanism study of Xuanfei Baidu Fang for the treatment of elderly patients with moderate COVID-19 infection
Active, not recruitingChiCTR2300070992
Start: 2023-05-01Updated: 2023-06-04
Phase 1
Unknown Phase
Plasma exchange for HBV-related liver failure: a randomised controlled trial
RecruitingChiCTR-TRC-13003392
Start: 2013-05-01Updated: 2017-04-18
A randomized controlled trial for the efficacy of ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19)
RecruitingChiCTR2000030006
Start: 2020-02-19Updated: 2020-02-25
Multicenter Registration Study of Acute Anterior Circulation Large Vessel Occlusive Stroke with Low ASPECTS
RecruitingChiCTR2000033751
Start: 2020-06-12Updated: 2021-11-29
Real-world Study of San Sang Shen Qi Decoction Combined with Liuzijue qigong in the Treatment of Shenqi Deficiency Syndrome in Moderate-severe Stable COPD
Active, not recruitingChiCTR2400085905
Start: 2024-07-01Updated: 2024-07-08
Tenecteplase for MRI-Selected Patients with Branch Atheromatous Disease in the Extended Time Window (4.5-24 Hours):A Prospective, Randomized, Open-Label, Blinded Endpoint, Multicenter Study
Active, not recruitingChiCTR2500112308
Start: 2025-11-20Updated: 2025-11-17